Portfolio company
Hemotune
Switzerland · £14.0m raised
Raised
£14.0m
Latest stage
Series B
Rounds recorded
1
Backed by
5 investors
Sectors
About
This company develops a magnetic blood purification platform using nanoengineered beads to remove specific disease-causing substances for patients with sepsis or requiring gene therapy.
SourceFunding history · 1
Similar companies
PATH EX, Inc.
This company develops a medical device that removes bacteria and endotoxins from the bloodstream to treat sepsis patients in clinical settings.
SepsiScan
This company develops bedside imaging devices for real-time microcirculation monitoring and early sepsis diagnosis for intensive care units and hospitals.
Advanced Perfusion Diagnostics
This company develops single-use devices for non-invasive, continuous microcirculation assessment and early sepsis detection for clinicians in critical care and surgical settings.
Abionic
This company develops nanofluidic point-of-care diagnostic platforms and blood tests for healthcare professionals to enable rapid detection of sepsis, allergies and iron deficiencies.
FAST Biomedical
This company develops medical technology for measuring blood volume and kidney function to assist healthcare professionals treating heart failure and sepsis patients.
Healionics
Healionics produces synthetic vascular grafts for dialysis patients to improve blood access and reduce complications such as infection and occlusion.
Septest
This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.
Akadeum Life Sciences
This company develops microbubble-based cell separation systems and kits for researchers and clinicians working in diagnostics and cell therapy.
